Int J Med Sci 2018; 15(14):1694-1701. doi:10.7150/ijms.27593 This issue Cite

Research Paper

Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw

Rui Yang1*, Yurong Tao2*, Chao Wang1, Yi Shuai3✉, Lei Jin3✉

1. Department of Stomatology, PLA Army General Hospital, Beijing, 100000, People's Republic of China;
2. Department of Gastroenterology, PLA Army General Hospital, Beijing, 100000, People's Republic of China;
3. Department of Stomatology, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu 210002, People's Republic of China.
*These authors contributed equally to the study.

Citation:
Yang R, Tao Y, Wang C, Shuai Y, Jin L. Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw. Int J Med Sci 2018; 15(14):1694-1701. doi:10.7150/ijms.27593. https://www.medsci.org/v15p1694.htm
Other styles

File import instruction

Abstract

There is no defined biomarker for BRONJ diagnosis with satisfactory performance in clinic. In this study, we established the BRONJ model and selected 7 microRNAs as candidate for BRONJ diagnosis from microRNA microarray reported by other research. Dysregulated microRNAs during BRONJ were detected and validated in two independent animal experiments using serum samples. In the first part, serum miR-21, miR-23a and miR-145 were significantly altered in between BRONJ and control group. And an Indice was constructed as -0.032+(0.154×miR-21)+(0.145×miR-23a)+(-0.700×miR-145) using logistic regression model to improve diagnostic performance. The performance of Indice to differentiate BRONJ subjects from control group was analyzed as AUC of 0.82 (95% CI, 0.72-0.92) or 0.85 (95% CI, 0.73-0.97) in the first or second part. Moreover, the predictive performance of Indice to discriminate BRONJ-1w and BRONJ-4w from control group was displayed as AUC of 0.65 (95% CI, 0.47-0.84) or 0.75 (95% CI, 0.60-0.91), which was better than individual circulating microRNAs. In addition, the expressions of candidate microRNAs were validated in human samples. Consequently, we investigated a combined Indice constructed with circulating microRNAs for BRONJ diagnosis and prediction.

Keywords: bisphosphonate-related osteonecrosis of the jaw, circulating microRNA, biomarker, diagnosis


Citation styles

APA
Yang, R., Tao, Y., Wang, C., Shuai, Y., Jin, L. (2018). Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw. International Journal of Medical Sciences, 15(14), 1694-1701. https://doi.org/10.7150/ijms.27593.

ACS
Yang, R.; Tao, Y.; Wang, C.; Shuai, Y.; Jin, L. Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw. Int. J. Med. Sci. 2018, 15 (14), 1694-1701. DOI: 10.7150/ijms.27593.

NLM
Yang R, Tao Y, Wang C, Shuai Y, Jin L. Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw. Int J Med Sci 2018; 15(14):1694-1701. doi:10.7150/ijms.27593. https://www.medsci.org/v15p1694.htm

CSE
Yang R, Tao Y, Wang C, Shuai Y, Jin L. 2018. Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw. Int J Med Sci. 15(14):1694-1701.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image